On November 6, 2021 Philogen reported its attendance at the Festival of Biologics Basel on November 10, 2021 (Press release, Philogen, NOV 6, 2021, View Source [SID1234594678])

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Lisa Nadal, 3-year PhD student at Philogen, is giving a lecture entitled "A novel IL12-based immunocytokine targeting Fibroblast Activation Protein (FAP) for the treatment of cancer"

Roberto De Luca, Head of Antibody Therapeutics at Philogen, is giving a lecture entitled "Tripokin: tumor targeted delivery of IL2 potentiated by TNF"

Samuele Cazzamalli, Head of Small Molecule Therapeutics at Philogen, is giving a lecture entitled "Pan-tumoral Small Molecule-Drug Conjugates targeting Fibroblast Activation Protein in solid lesions"

Dario Neri, co-founder, CEO and CSO, is giving a lecture entitled "Antibody-cytokine fusions directed against splice variants of fibronectin for the therapy of disseminated cancer: from discovery to Phase III clinical trials"